Nostrum Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NOSTRUM LABS, and what generic and branded alternatives to NOSTRUM LABS drugs are available?
NOSTRUM LABS has fifty-nine approved drugs.
Drugs and US Patents for Nostrum Labs
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nostrum Labs Inc | ACETAMINOPHEN AND CODEINE PHOSPHATE | acetaminophen; codeine phosphate | TABLET;ORAL | 088629-002 | Mar 6, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Nostrum Labs | ACILAC | lactulose | SOLUTION;ORAL, RECTAL | 073685-001 | May 28, 1993 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Nostrum Labs Inc | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE | homatropine methylbromide; hydrocodone bitartrate | SYRUP;ORAL | 210663-001 | Jun 11, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Nostrum Labs Inc | LEVETIRACETAM | levetiracetam | TABLET;ORAL | 090511-004 | Aug 18, 2011 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Nostrum Labs Inc | NITROFURANTOIN | nitrofurantoin | SUSPENSION;ORAL | 201355-001 | Aug 14, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Nostrum Labs Inc | DAPSONE | dapsone | TABLET;ORAL | 203887-002 | May 6, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.